Follow

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow
LinkedIN Twitter Instagram Youtube
Contact
LinkedIN Twitter Instagram Youtube

SFDA approves registration of ‘Tzield’ for delaying type1 diabetes

by
August 24, 2025
SFDA approves registration of ‘Tzield’ for delaying type1 diabetes SFDA approves registration of ‘Tzield’ for delaying type1 diabetes

Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in adults and pediatric patients

by
Updated
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement

Read more